Core Viewpoint - The company, Jianfa Zhixin, is advancing its IPO process and is positioned as a leading national distributor of high-value medical devices, focusing on digital transformation and innovative management solutions in the medical device supply chain [1][4]. Group 1: Business Model and Management Innovation - Jianfa Zhixin has developed a "national integrated medical device distribution hub," providing comprehensive management services that cover channel access, warehousing logistics, distribution management, circulation information, and financial settlement [2]. - The company collaborates deeply with numerous manufacturers and hospitals, utilizing a platform management model that reduces management difficulties for upstream manufacturers and enhances efficiency [2]. - Unlike traditional medical device companies that focus on single products or departments, Jianfa Zhixin offers diversified solutions that meet the procurement needs of various hospital departments [2]. Group 2: Digital Technology and Service Innovation - The company has established a digital supply chain management system for medical devices, applying modern technologies such as information management and IoT [3]. - Jianfa Zhixin's proprietary information management system utilizes unique device identification (UDI) to ensure compliance and accuracy in the supply chain, significantly optimizing operational efficiency [3]. - The company extends its digital management to hospitals, providing advanced centralized management services for medical consumables, which helps reduce inventory and operational costs [3]. Group 3: Financial Performance - Jianfa Zhixin's revenue and net profit are projected to grow significantly from 2022 to 2024, with revenues of 11.882 billion, 15.443 billion, and 17.923 billion respectively, and net profits of 189 million, 227 million, and 274 million [3]. Group 4: Market Position and Adaptability - The company has established a nationwide distribution center and regional operation network across three main business areas: high-value consumables, IVD diagnostic products, and centralized supply management, demonstrating strong adaptability to trends in the medical device distribution industry [4].